Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The losses keep coming ... @PharmaPinkSheet #pinksheet #pharma: JNJ, BMS’s IRA Loss Is First Time Court Rejects Industry’s First Amendment, Takings Claims https://t.co/BdNewGMlZb
JNJ, BMS’s IRA Loss Is First Time Court Rejects Industry’s First Amendment, Takings Claims https://t.co/LEVdKVvqVA #PinkSheet
As AstraZeneca files its IRA challenge to a federal appeals court, Bristol Myers Squibb and Johnson & Johnson are plotting their own appeals after a US judge dismissed their IRA lawsuits https://t.co/rI1OcPKwwY
Federal judges have ruled against drugmakers Johnson & Johnson and Bristol Myers Squibb in cases challenging the Medicare drug price negotiation program and the Inflation Reduction Act. The rulings add to the industry's string of defeats as the companies plan appeals after their lawsuits were dismissed.
